| NATIONAL UNIVERSITY CORPORATION TOTTORI UNIVERSITY Patent applications |
| Patent application number | Title | Published |
|---|
| 20110193073 | FULLERENE DERIVATIVE, COMPOSITION AND ORGANIC PHOTOELECTRIC CONVERSION ELEMENT - The present invention provides a fullerene derivative represented by the following formula (1). | 08-11-2011 |
| 20110193072 | FULLERENE DERIVATIVE, COMPOSITION, AND ORGANIC PHOTOELECTRIC CONVERSION ELEMENT - The present invention provides a fullerene derivative represented by the following formula (1). | 08-11-2011 |
| 20110065197 | DIAGNOSTIC KIT FOR ALZHEIMER'S DISEASE, DIAGNOSTIC MARKER, AND DETECTION METHOD FOR INDICATOR OF PATHOLOGICAL STATE THEREOF - [Problems] The differential diagnosis of Alzheimer's disease as distinguished from other type of dementia and the diagnosis of Alzheimer's disease at such an early stage where neural cell death has not proceeded yet are important for the treatment of Alzheimer's disease. On the other hand, it is difficult to differentially diagnose Alzheimer's disease at an earlier stage by a diagnosis mainly made by questioning by a doctor or a diagnostic technique using phosphorylated tau or amyloid-β protein as an indicator. Thus, the development of a novel diagnostic technique has been demanded. | 03-17-2011 |
| 20110023138 | MAMMALIAN ARTIFICIAL CHROMOSOME VECTOR COMPRISING HUMAN CYTOCHROME P450 GENE (CLUSTER) AND NON-HUMAN MAMMALIAN ANIMAL RETAINING THE SAME - This invention relates to a mammalian artificial chromosome vector, which retains a human chromosome 7 fragment comprising human cytochrome P450 genes and is transmittable to progeny, wherein the human chromosome 7 fragment retains a region of approximately 1 Mb±500 Kb in size comprising at least a human CYP3A gene cluster, which region is located between chromosome markers AC004922 and AC073842, and to a non-human mammalian animal retaining the vector. | 01-27-2011 |
| 20110001093 | FULLERENE DERIVATIVE - Disclosed is an organic photoelectric converter having a layer containing a fullerene derivative represented by the formula (1) below. (In the formula (1), m represents an integer of 1-6; n represents an integer of 1-4; p represents an integer of 0-5; r represents an integer of 0-4; and Q represents a group represented by the formula (2) or (3) below. When there are a plurality of m's, they may be the same as or different from each other. In the formulae (2) and (3), R | 01-06-2011 |
| 20100298184 | SOLVENT COMPOSITION - A solvent composition includes a substance that is subject to oxidative alteration by an oxygen radical, and a compound that has a superoxide dismutase-mimetic activity that includes oxygen radical-removing capability. In the solvent composition of the invention, oxygen radicals can be removed by the compound having an superoxide dismutase-mimetic activity that includes oxygen radical-removing capability, and therefore the substance that is subject to oxidative alteration can be prevented from oxidizing. | 11-25-2010 |
| 20100248356 | hTERT GENE EXPRESSION REGULATORY GENE - Disclosed is a novel substance capable of regulating the expression of a telomerase reverse transcriptase gene in a cell of a mammal. A gene capable of regulating the expression of hTERT, comprising a nucleotide sequence depicted in SEQ ID No: 1 or 2. The expression of a telomerase reverse transcriptase gene can be inhibited by inhibiting the expression of the gene. By utilizing this mechanism, the expression of a telomerase reverse transcriptase gene can be regulated. | 09-30-2010 |
| 20100224829 | PHOSPHOR - Disclosed is a phosphor having high luminance, which is composed of M | 09-09-2010 |
| 20100184216 | hTERT GENE EXPRESSION REGULATORY GENE - Disclosed is a novel substance capable of regulating the expression of a telomerase reverse transcriptase gene in a cell of a mammal. A gene capable of regulating the expression of hTERT, comprising a nucleotide sequence depicted in SEQ ID No: 1 or 2. The expression of a telomerase reverse transcriptase gene can be inhibited by inhibiting the expression of the gene. By utilizing this mechanism, the expression of a telomerase reverse transcriptase gene can be regulated. | 07-22-2010 |
| 20100184208 | hTERT GENE EXPRESSION REGULATORY GENE - Disclosed is a novel substance capable of regulating the expression of a telomerase reverse transcriptase gene in a cell of a mammal A gene capable of regulating the expression of hTERT, comprising a nucleotide sequence depicted in SEQ ID No: 1 or 2. The expression of a telomerase reverse transcriptase gene can be inhibited by inhibiting the expression of the gene. By utilizing this mechanism, the expression of a telomerase reverse transcriptase gene can be regulated. | 07-22-2010 |
| 20100010054 | THERAPEUTIC AGENT FOR AMYOTROPHIC LATERAL SCLEROSIS - A novel therapeutic agent for amyotrophic lateral sclerosis. A therapeutic agent for amyotrophic lateral sclerosis, including a compound having xanthine dehydrogenase inhibitory action and not acting as a substrate for the purine salvage pathway. | 01-14-2010 |
| 20090124794 | hTERT GENE EXPRESSION REGULATORY GENE - Disclosed is a novel substance capable of regulating the expression of a telomerase reverse transcriptase gene in a cell of a mammal. A gene capable of regulating the expression of hTERT, comprising a nucleotide sequence depicted in SEQ ID No: 1 or 2. The expression of a telomerase reverse transcriptase gene can be inhibited by inhibiting the expression of the gene. By utilizing this mechanism, the expression of a telomerase reverse transcriptase gene can be regulated. | 05-14-2009 |
